Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Clinical trial NCT01351350 · COMPLETED
Trial details
- NCT number
- NCT01351350
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-28
- Primary completion
- 2017-09-15
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.